Alvotech’s Iceland Expansion Will Double Capacity
Extension Of Reykjavik Facility Expected To Be Complete By End Of 2022
Executive Summary
As Alvotech advances towards launches around the world for its portfolio of biosimilars, the firm is ramping up capacity at its Reykjavik facility.